# DEFERASIROX
> **ANDA210727** · Abbreviated New Drug Application (Generic) · Sponsor: STEVENS J · Approved 2020-06-15
## Drug
- **FDA Application Number:** ANDA210727
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEFERASIROX
- **Generic name:** DEFERASIROX
- **Active ingredients:** DEFERASIROX
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** STEVENS J
- **Manufacturer:** Amneal Pharmaceuticals NY LLC
- **First approval:** 2020-06-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210727)
---
*AI Analytics · CC0 1.0*